Efficacy of Focused Extracorporeal Shock Wave Therapy in Chronic Low Back Pain: A Prospective Randomized 3-Month Follow-Up Study

11 June 2022 : Clinical Research

Katarzyna Rajfur^1ABDEF, Joanna Rajfur^1ABDEF, Tomasz Matusz^1ABF, Karolina Walewicz^1ABD, Robert Dymarek^2ABDEFG*, Kuba Ptaszkowski

^3ABCD, Jakub Taradaj^4ACDEFG

DOI: 10.12659/MSM.936614

Med Sci Monit 2022; 28:e936614

Background Material and Methods Results Discussion Conclusions References

Related articles Order reprints Share article Share by email

View HTML version

Table 3 VAS scores in both groups.

Variable	Measure	Experimental fESWT group							Control fESWT group
Variable	Measure	χ̄	Me	Min	Max	Q1	Q3	SD	χ̄	Me	Min	Max	Q1	Q3	SD
VAS score	Before	7.2	8.0	4.0	10.0	5.0	8.5	1.9	7.3	7.0	5.0	10.0	6.0	9.0	1.7
	After	1.5	1.0	1.0	3.0	1.0	2.0	0.6	2.9	3.0	1.0	6.0	2.0	3.0	1.3
	1 month FU	1.7	1.0	1.0	5.0	1.0	2.0	1.1	3.1	3.0	1.0	7.0	2.0	4.0	1.7
	3 months FU	2.0	1.5	1.0	5.0	1.0	3.0	1.2	3.3	3.0	1.0	8.0	2.0	4.0	1.9
value (main effect)^*		<0.001							<0.001
p-value (multiple comparisons)^**		Before vs after: p<0.001Before vs 1 month: p<0.001Before vs 3 months: p<0.001After vs 1 month: p=1.000After vs 3 months: p=1.0001 month vs 3 months: p=1.000							Before vs after: p<0.001Before vs 1 month: p<0.001Before vs 3 months: p<0.001After vs 1 month: p=1.000After vs 3 months: p=1.0001 month vs 3 months: p=1.000
fESWT – focused extracorporeal shock wave; n – number of individuals; χ̄ – mean; Me – median; Min – minimum value; Max – maximum value; Q1 – lower quartile; Q3 – upper quartile; SD – standard deviation; FU – follow-up. ^* Friedman’s ANOVA; ^** Dunn’s test.

Back to the Article